Penn inventors make the mRNA-based COVID vaccines possible

Drew Weissman, MD, PhD, the Roberts Family Professor of Vaccine Research, and Katalin Karikó, PhD, an adjunct professor of Neurosurgery at Penn, have been awarded multiple prestigious prizes.

Philly just ranked high on a global list of startup ecosystems. These local leaders aren’t surprised

iladelphia landed a spot in the overall top 30 of Startup Genome's Global Startup Ecosystem Report. The city scored highest for its market reach and talent.

Luxturna inventor Jean Bennett starts a new gene therapy company to tackle rare diseases left behind by pharma, VCs

Jean Bennett, who designed and co-developed Luxturna, approved in 2018 for a rare form of blindness, had kept building new gene therapies for eye diseases at her University of Pennsylvania lab.

Katalin Karikó and Drew Weissman named to the 2022 National Inventors Hall of Fame

National Inventors Hall of Fame, in partnership with the United States Patent and Trademark Office, is excited to announce the 2022 Class of Inductees.

Penn engineers will develop on-demand, on-site mRNA manufacturing

With an NSF grant, Penn Engineering researchers are developing a new manufacturing technique that would be able to produce mRNA sequences in a way that removes the need for cryogenic temperatures.

Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25

long with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma.

At-home COVID-19 results with the click of a smartphone

chers have developed a highly-sensitive rapid antigen test that can detect small loads of SARS-CoV-2

Webinar Recording: Latest Trends in Life Science Investing

PCI hosted a webinar on Septembe 13, 2021 focused on the latest trends in the venture capital landscape. The speaker was Barbara Schilberg, Managing Director and Chief Executive Officer of BioAdvance.

Jean Bennett, M.D., Ph.D., joins REGENXBIO Board of Directors

She will serve as a member of REGENXBIO's Nominating and Corporate Governance Committee. 

Inspired by the late Tachi Yamada, Jim Wilson launches new nonprofit targeting underserved ultra-rare diseases

A group of powerhouse biotech leaders is coming together to launch a new nonprofit, one aimed at delivering therapies to rare disease populations they believe pharma is leaving behind.


Success Stories

Highlights of the PCI news focused on Penn commercialization accomplishments

All Success Stories
Skip to content